Third-party reimbursement for pharmacist instruction about antihemophilic factor.
The trial and evaluation of pharmacy education program to teach a 14-year-old hemophiliac to self-administer Factor VIII at home is described. The home therapy program realized a cost saving of $20,230 for this patient for the first year; school attendance increased 15%. The results of the trial were used to justify a professional fee from Blue Cross of Central Ohio for the pharmacist's educational services.